Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Journal of Clinical Investigation
|
September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Lancet. Oncology
|
September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial
Yoshie Umemura, Daniel Orringer, Larry Junck, et al.
Research Square
|
September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano
|
May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy
Mahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas
Maria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Biorxiv : the Preprint Server for Biology
|
April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Journal of Clinical Investigation
|
September 20, 2022
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase, Kaushik Banerjee, Anzar A Mujeeb, et al.
The Lancet. Oncology
|
September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial
Yoshie Umemura, Daniel Orringer, Larry Junck, et al.
Research Square
|
September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target
Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
ACS Nano
|
May 26, 2022
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy
Mahmoud S Alghamri, Kaushik Banerjee, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2023
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas
Maria B Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, et al.
Page
of 4